Concepedia

Matouš Hrdinka

MH

Statistics

Publications

18

Citations

940

H-Index

15

Active since

2009

Affiliations

University of Ostrava(Current)

University Hospital Ostrava

Czech Academy of Sciences

Czech Academy of Sciences, Institute of Molecular Genetics

Ludwig Cancer Research

Matouš Hrdinka is an author at University of Ostrava specializing in life sciences, cell signaling, and signal transduction.

ORCID

Publications per year

2009–2024

18

Publications

18

CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling

Matouš Hrdinka, Berthe Katrine Fiil, Mattia Zucca et al. · Cell Reports · 2016 · 153 citations · Full text

, , +17

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling

P.R. Elliott, Derek Leske, Matouš Hrdinka et al. · Molecular Cell · 2016 · 153 citations · Full text

, , +4

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors

Peter Canning, Qui Ruan, Tobias Schwerd et al. · Chemistry & Biology · 2015 · 126 citations · Full text

, , +17

Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling

Matouš Hrdinka, Lisa Schlicher, Bing Dai et al. · The EMBO Journal · 2018 · 79 citations · Full text

, , +11

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma

Tomáš Jelı́nek, Renata Bezděková, David Žihala et al. · Journal of Clinical Oncology · 2022 · 75 citations · Full text

, , +17

1–5 of 18